HIV Latency TORn Down

Mauro Giacca

doi:10.1016/j.chom.2016.11.009

HIV Latency TORn Down

Mauro Giacca^*

^*Corresponding author for this work

Cardiovascular Medicine & Sciences

Research output: Contribution to journal › Short survey › peer-review

5 Citations (Scopus)

Abstract

Combination therapy for HIV infection is effective at controlling disease but fails to eradicate the virus because a persistent reservoir of cells harbors latent HIV DNA. In this issue of Cell Host & Microbe, Besnard et al. (2016) show that the mTOR kinase is essential to reactivate HIV from latency.

Original language	English
Pages (from-to)	700-702
Number of pages	3
Journal	Cell Host and Microbe
Volume	20
Issue number	6
DOIs	https://doi.org/10.1016/j.chom.2016.11.009
Publication status	Published - 14 Dec 2016

Keywords

HIV
latency
mTOR
therapy

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.chom.2016.11.009

Cite this

@article{8c0114a0f54e43d0b7efd6ee812c0b91,

title = "HIV Latency TORn Down",

abstract = "Combination therapy for HIV infection is effective at controlling disease but fails to eradicate the virus because a persistent reservoir of cells harbors latent HIV DNA. In this issue of Cell Host & Microbe, Besnard et al. (2016) show that the mTOR kinase is essential to reactivate HIV from latency.",

keywords = "HIV, latency, mTOR, therapy",

author = "Mauro Giacca",

year = "2016",

month = dec,

day = "14",

doi = "10.1016/j.chom.2016.11.009",

language = "English",

volume = "20",

pages = "700--702",

journal = "Cell Host and Microbe",

issn = "1931-3128",

publisher = "Cell Press",

number = "6",

}

TY - JOUR

T1 - HIV Latency TORn Down

AU - Giacca, Mauro

PY - 2016/12/14

Y1 - 2016/12/14

N2 - Combination therapy for HIV infection is effective at controlling disease but fails to eradicate the virus because a persistent reservoir of cells harbors latent HIV DNA. In this issue of Cell Host & Microbe, Besnard et al. (2016) show that the mTOR kinase is essential to reactivate HIV from latency.

AB - Combination therapy for HIV infection is effective at controlling disease but fails to eradicate the virus because a persistent reservoir of cells harbors latent HIV DNA. In this issue of Cell Host & Microbe, Besnard et al. (2016) show that the mTOR kinase is essential to reactivate HIV from latency.

KW - HIV

KW - latency

KW - mTOR

KW - therapy

UR - http://www.scopus.com/inward/record.url?scp=85006127309&partnerID=8YFLogxK

U2 - 10.1016/j.chom.2016.11.009

DO - 10.1016/j.chom.2016.11.009

M3 - Short survey

C2 - 27978431

AN - SCOPUS:85006127309

SN - 1931-3128

VL - 20

SP - 700

EP - 702

JO - Cell Host and Microbe

JF - Cell Host and Microbe

IS - 6

ER -

HIV Latency TORn Down

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this